Hyperfine, Inc. (HYPR)
0.761
-0.04
(-4.89%)
USD |
NASDAQ |
Oct 15, 14:56
Hyperfine EPS Diluted (Quarterly) : -0.0932 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0932 |
| March 31, 2026 | -0.0883 |
| December 31, 2025 | -0.0628 |
| September 30, 2025 | -0.1394 |
| June 30, 2025 | -0.1182 |
| March 31, 2025 | -0.1244 |
| December 31, 2024 | -0.1421 |
| September 30, 2024 | -0.1421 |
| June 30, 2024 | -0.141 |
| March 31, 2024 | -0.1369 |
| December 31, 2023 | -0.149 |
| September 30, 2023 | -0.1505 |
| Date | Value |
|---|---|
| June 30, 2023 | -0.1494 |
| March 31, 2023 | -0.1716 |
| December 31, 2022 | -0.185 |
| September 30, 2022 | -0.1866 |
| June 30, 2022 | -0.3291 |
| March 31, 2022 | -0.338 |
| December 31, 2021 | -0.3709 |
| September 30, 2021 | -0.6188 |
| June 30, 2021 | -0.5504 |
| March 31, 2021 | -4.817 |
| December 31, 2020 | -0.2723 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 0.5324 |
| AngioDynamics, Inc. | -0.1689 |
| Alphatec Holdings, Inc. | -0.1647 |
| AtriCure, Inc. | 0.1832 |
| Baxter International, Inc. | 0.2432 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.298M |
| Revenue (Quarterly) | 3.904M |
| Total Expenses (Quarterly) | 13.20M |
| Enterprise Value | 53.49M |
| Gross Profit Margin (Quarterly) | 50.72% |
| Profit Margin (Quarterly) | -238.2% |
| Earnings Yield | -50.42% |
| Normalized Earnings Yield | -48.41 |